Who We Are
The Worst Pain Ever® digital platform is the world’s largest online kidney stone patient community!
We seek to improve patients’ well-being by empowering them with useful information, supporting them through our active community and bringing joy through our relatable content.
Our digital urology initiative is powered by Dornier MedTech, one of the most trusted names in urology that continues to spearhead innovation. We are pushing the envelope in digital urology to provide holistic care to patients who are seeking treatment and community as they work through their conditions online and in real life.
WHY DIGITAL UROLOGY WITH WORST PAIN EVER®
30M Americans may suffer from Kidney Stones in their lifetime1
of Kidney Stones2
suspected kidney stones4
- Scales, C. D., Smith, A. C., Hanley, J. M., & Saigal, C. S. (2012). Prevalence of kidney stones in the United States. European Urology, 62(1), 160–165. https://doi.org/10.1016/j.eururo.2012.03.052
- Litwin MS, Saigal CS: Table 14-47: Economic impact of urologic disease. In: Urologic Diseases in America. NIH Publication 12-7865. Washington, DC, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services, 2012, p 486 https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/urologic-diseases-in-america
- Saigal, C. S., Joyce, G., Timilsina, A. R., & the Urologic Diseases in America Project. (2005). Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management? Kidney International, 68(4),
- Hyams, E. S., Korley, F. K., Pham, J. C., & Matlaga, B. R. (2011). Trends in imaging use during the emergency department evaluation of Flank pain. Journal of Urology, 186(6), 2270–2274.https://doi.org/10.1016/j.juro.2011.07.079
- Premji, B. (2017). (rep.). Urological Devices – Market Insights – United States. Clarivate.
What We Do
Through our digital health approach, we are meeting kidney stone patients where they are and providing them with actionable insights, to drive impact on their health behaviors and outcomes.
Our digital health journey began with the simple goal of supporting kidney stone patients through their worst pain ever. We empower them with useful information, support them through our active community and bring joy through our relatable content.
Today, our clinically-backed WPE Wellness™ Program strives to improve kidney stone patients’ health outcomes and reduce healthcare costs. From medically-reviewed toolkits, targeted lifestyle recommendations to robust community support, we are adopting a holistic approach towards enriching the kidney stone patient experience.
What is the WPE Wellness™ program?
Our WPE Wellness™ program is specially designed to help kidney stone patients reduce the risk of recurrence and complications, through comprehensive patient education and guided intervention at various stages of their journey. Through our articles and toolkits, we aim to support patients in making better lifestyle and treatment decisions.
Where do we get our information from?
Medical accuracy is important to us, and to the patients whom we serve.
We take pride in ensuring that our articles and toolkits are backed by studies from peer-reviewed journals and verified by a panel of esteemed urologists, known as our Medical Advisory Board. They help to ensure that the information we provide is relevant, accurate and up-to-date.
Meet our medical advisory board
Dr Linda Shortliffe
Dr Linda M. Dairiki Shortliffe is the Stanley McCormick Memorial Professor Emerita of Urology at Stanford University, where she previously served as Department Chair of Urology.
With her extensive knowledge and experience, she is dedicated to improving the lives of kidney stone patients through her research and guidance.
Dr Kymora Scotland
Dr Kymora Scotland is an endourologist practitioner and an Assistant Professor of Urology in UCLA. She also holds the role as Director of Endourology Research and Associate Director of Endourology Fellowship Program.
She has clinical expertise in the treatment of kidney stones, and works with patients to treat stones and other surgical issues through minimally invasive surgery.
Dr Simon Conti
Dr Simon Conti is a Clinical Associate Professor of Urology at Stanford University School of Medicine. He has clinical expertise in the treatment of kidney stones, and has a special interest in the treatment of urologic conditions.
Dr Conti is a founding member of the Stanford Urolithiasis Project, aimed at studying environmental risk factors in urinary stone disease, such as ethnic disparities.